Little is known about the indicators and special characteristics of veno-venous extracorporeal life support (VV-ECLS) in patients with a severe asthma attack. We included a new case with near-fatal asthma (NFA) in a medical intensive care unit (MICU). Cases with severe asthma attack requiring VV-ECLS from 1980 to 2018 from the literature were added. The general information, laboratory examinations, treatments and outcomes were summarized. There were seventeen cases with severe asthma attack supported with VV-ELCS from the literature, including our case; six of them received extracorporeal CO 2 removal (ECCO 2 R). The average age of the patients was 37 (±18) years, and only three had an underlying disease.
Introduction
Severe and refractory asthma attacks often require invasive ventilation, which is attributed to 30% mortality [1, 2] .
Mechanical ventilation might lead to several complications attributed to the related mortality of 7-8% [3] [4] [5] . Extracorporeal life support (ECLS) is an alternative strategy, allowing time for "inflammation resolution of the airway" and avoiding complications effectively. There have been several scattered case reports on the successful treatment of a severe asthma attack by VV-ECLS in recent years. The selected patients had some common characteristics, but there was no systematic summary of these cases. Thus, we describe herein a new case from our centre and a comprehensive review of cases reported in the literature [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , with a particular focus on the indicators and the special characteristics of VV-ECLS in severe asthma attacks compared with other diseases. later, improving gradually as the therapy continued (Table I) .
The chest X-ray (CXR) on the first day of admission showed bilateral hyperventilation and a narrow cardiac shadow without obvious infiltration, while pulmonary atelectasis appeared the day after ECLS support ( Figure 1) . A fibro-optic bronchoscopy was subsequently performed, which revealed a large amount of thick bronchial secretions occluding the middle lobe of the right lung and the upper and lingual lobe of the left lung. Mucous plugs could be observed in bronchoalveolar lavage fluid (BALF) ( Figure 2 ). Cytological classification of the BALF revealed that the majority were neutrophil granulocytes, which accounted for 57.5% of the cells, while the eosinophil granulocytes accounted for 5%.
VV-ECLS was continued for 120 hours (5 days), and the intubation for IPPV was removed after 156 hours. There was no ECLS-related complication. The patient transferred to the ward on the 13 th day and was discharged on the 23 rd day after admission. Table I : Changes in ventilator parameters, respiratory mechanics and ABG ABG, arterial blood gas; ECLS, extracorporeal life support; FiO 2 , inspiratory fraction of oxygen; RR, respiratory rate; PEEP, positive end-expiratory pressure; VT, tidal volume; PS/PC, pressure support/ pressure control; P peak , peak airway pressure; P plat , plateau pressure; R, airway resistance; C, respiratory compliance; PEEP i , intrinsic level of positive end-expiratory pressure; PaCO 2 , partial pressure of arterial carbon dioxide; PaO 2 , partial pressure of arterial oxygen; Lac, lactate 
Is ECCO 2 R better than VV-ECMO?
ECCO 2 R could effectively remove CO 2 with low blood flow; however, it was ineffective in improving oxygenation [27] .
As our study revealed, severe and refractory hypercapnia was a more common complication (70.6%) than severe hypoxemia (11.8%) in patients with a severe asthma attack; meanwhile, the average blood flow of the patients receiving VV-ECLS was 2.3 (±1.2) L/min, which was relatively lower than that of patients with hypoxemic respiratory failure, making ECCO 2 R possible. In addition, ECCO 2 R could be achieved by placing just one double-lumen cannula conveniently [12, 16] . We speculated that patients without severe hypoxemia could receive ECCO 2 R as the first choice when requiring ECLS.
Whether bronchoscopy is necessary and safe?
Bronchoscopy is a useful tool for phenotyping asthma with objective data obtained from BAL, endobronchial biopsy, and brushings for the direction of therapeutic decisions [28] [29] [30] . Moreover, thick bronchial secretions and mucous plugs were commonly observed in critically ill asthma patients, which obstructed the airway, causing persistent high airway resistance and aggravating hyperinflation. In our case, aggressive pulmonary hygiene, including frequent bronchoscopies, was employed to improve the patient's respiratory status. It also enables pulmonary hygiene that could be lifesaving in the case of an asthma-associated plastic bronchitis [10] . ECLS made it possible and safe for aggressive pulmonary hygiene in patients with a severe asthma attack.
The limitations of our study
The limitation of this study is that the number of selected cases is relatively small and may not represent all patients with a severe asthma attack. There is still an urgent need to expand the sample size of the study and perform a case-controlled study comparing patients with VV-ECLS and conventional mechanical ventilation in the future.
